Clinical Trials Browser

INDUSTRY × Has results × Pluvicto × Clear all

NCT04689828 2026-03-23

PSMAfore

Phase 3 Active not recruiting

469 enrolled 11 charts 1 FDA

Prostatic Neoplasms

NCT03511664 2025-01-13

VISION

Phase 3 Completed

861 enrolled 39 charts 1 FDA

Prostatic Neoplasms

NCT03042312 2021-03-24

RESIST-PC

Phase 2 Terminated

71 enrolled 15 charts

Metastatic Castration Resistant Prostate Cancer